Alaunos Therapeutics reduces stockholder quorum requirement to one-third of voting power

Alaunos Therapeutics, Inc.

Board adopted Second Amended and Restated By-Laws effective September 16, 2026.
Quorum for stockholder meetings lowered from majority to one-third of outstanding voting power.
Board and committee quorum unchanged at majority.
Amendment includes conforming, clarifying, and non-substantive changes.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.